DMK
ADMA icon

David M. Knott’s ADMA Biologics ADMA Stock Holding History

David M. Knott’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,457
Closed -$42K – 131
2020
Q4 		$42K Sell
21,457
-43,700
-67% -$91.9K 0.02% 93
2020
Q3 		$156K Sell
65,157
-135,000
-67% -$370K 0.09% 64
2020
Q2 		$586K Buy
200,157
+59,400
+42% +$171K 0.32% 46
2020
Q1 		$405K Buy
+140,757
New +$487K 0.26% 51

Other funds holding ADMA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

David M. Knott's ADMA Position: Q1 2021 in Review

David M. Knott sold out of ADMA Biologics (ADMA) in Q1 2021, closing a stake of 21,457 shares — an estimated $42K sold.

David M. Knott first reported a position in ADMA in Q1 2020 and held it in 4 quarters. The position peaked at $586K in Q2 2020. 105 funds tracked by Wall St. Rank hold ADMA as of Q1 2021.

  • David M. Knott reported no remaining ADMA Biologics position as of Q1 2021 after selling out during the quarter.
  • David M. Knott sold 21,457 ADMA Biologics shares in Q1 2021, an estimated $42K.
  • David M. Knott first reported a position in ADMA Biologics in Q1 2020 and held it in 4 quarters.
  • David M. Knott's ADMA Biologics position peaked at $586K in Q2 2020.
  • 105 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2021.

Based on David M. Knott's 13F filing for Q1 2021, filed 13 May 2021.